Skip to main content
DIRUI INDUSTRIAL CO.,LTD. logo

DIRUI INDUSTRIAL CO.,LTD. — Investor Relations & Filings

Ticker · 300396 ISIN · CNE100001XS7 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,689 across all filing types
Latest filing 2021-01-12 Major Shareholding Noti…
Country CN China
Listing Shenzhen Stock Exchange 300396

About DIRUI INDUSTRIAL CO.,LTD.

https://www.dirui.com.cn

DIRUI INDUSTRIAL CO.,LTD. specializes in the research, development, manufacturing, and distribution of medical laboratory instruments and diagnostic reagents. The company provides comprehensive solutions for in-vitro diagnostics (IVD), focusing on several key clinical areas including urinalysis, biochemistry, hematology, and chemiluminescence immunoassay. Its product portfolio features high-throughput automated analyzers and integrated laboratory systems designed to enhance diagnostic efficiency and accuracy. DIRUI serves a global market, providing medical institutions and laboratories with a wide range of diagnostic tools, from urine sediment analysis to vaginal secretion testing. The company emphasizes technological innovation and quality control to support clinical decision-making and patient care through reliable laboratory automation and standardized testing protocols.

Recent filings

Filing Released Lang Actions
关于控股股东股份质押的公告
Major Shareholding Notification Classification · 95% confidence The document is an announcement regarding the pledge of shares by the controlling shareholder of the company. It details the number of shares pledged, the purpose of the pledge, the controlling shareholder's background, and assurances that the pledge will not affect company control or operations. There are no financial statements, earnings data, or management discussion of financial results. The document is a regulatory announcement about a capital-related event (share pledge) but does not report on financing activities like new capital raising or issuance. It is not a full financial report, earnings release, or management report. The content fits best under a regulatory announcement category related to shareholding and capital structure disclosures. Given the specific nature of the announcement about share pledge by a major shareholder, it aligns most closely with the category for Major Shareholding Notification (MRQ). The document length is short (2199 characters), and it is a direct announcement, not a report publication notice or certification. Therefore, the classification is MRQ with high confidence.
2021-01-12 Chinese
关于召开2021年第一次临时股东大会的通知
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a detailed notice about the convening of the 2021 first extraordinary general meeting (临时股东大会) of Dirui Medical Technology Co., Ltd. It includes information about the meeting date, voting methods (on-site and online), registration procedures, agenda items (amendments to the company articles of association), and proxy forms. There is no financial data or results reported, nor is it a transcript or presentation. It is a formal announcement inviting shareholders to participate and vote on specific proposals at the meeting. This fits the definition of a Proxy Solicitation & Information Statement (PSI), which provides materials sent to shareholders to inform and request votes for meetings. The document is not a report of voting results (DVA), nor an announcement of report publication (RPA). Therefore, the correct classification is PSI with high confidence.
2021-01-12 Chinese
公司章程
Governance Information Classification · 100% confidence The document is titled as the "章程" (Articles of Association or Company Bylaws) of 迪瑞医疗科技股份有限公司. It contains detailed provisions about the company's organization, shareholder rights, board of directors, management, financial accounting, profit distribution, and other governance matters. It references Chinese company law and securities law, and includes detailed rules on shareholder meetings, board responsibilities, share issuance, and other corporate governance topics. There is no indication that this is a financial report, earnings release, or announcement. Instead, it is a governance document outlining the internal rules and structure of the company. Therefore, the document fits the category of Governance Information (CGR). The document length (15,000 characters) and content confirm it is the full governance charter, not a brief announcement or summary.
2021-01-12 Chinese
关于公司产品获得CE认证的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the receipt of CE certification for nine medical device products. It includes product details, clinical uses, and implications for market access and competitiveness. There are no financial statements, management discussions, or regulatory filings related to financial performance. The document is relatively short (1959 characters) and serves as a formal announcement of a product certification event rather than a financial or regulatory report. It does not fit into categories like Annual Report, Interim Report, or Earnings Release. It is also not related to board changes, voting results, or legal proceedings. The best fitting category is Regulatory Filings (RNS) as a general announcement that does not fit other specific categories.
2021-01-12 Chinese
关于修改《公司章程》的公告
Governance Information Classification · 95% confidence The document is an announcement regarding amendments to the company's Articles of Association (公司章程). It details specific changes to the company's governance documents and mentions that these changes were approved by the board and will be submitted to the shareholders' meeting for approval. There is no financial data, no report attached or referenced as published, and no mention of financial results or regulatory certifications. The content focuses on governance structure changes, specifically amendments to the company's bylaws. Therefore, this fits best under Governance Information (CGR). The document length is short and it is not a report publication announcement or regulatory filing. Hence, the classification is CGR with high confidence.
2021-01-12 Chinese
关于获得发明专利证书的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement from a company about receiving an invention patent certificate. It contains no financial data, no mention of financial results, no regulatory filings related to financial performance, and no meeting or voting information. It is a regulatory announcement about intellectual property rights. The document length is only 642 characters, indicating it is a brief announcement rather than a detailed report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2021-01-08 Chinese

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.